Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe
Join us on-demand for an insightful discussion with our experts on one of the most important issues facing the UK pharma sector.

Sector specific concerns in the wake of the Brexit vote include potential changes to drug approval regulations, movement of researchers and executives into and out of the UK, the impact on investment and trade, and more.

Join:
  • Steve Bates, Chief Executive Officer, BIA
  • Virginia Acha, Executive Director, ABPI
  • Jo Pisani, Partner, PwC
  • Lindsey Barras, Director in Global Immigration, PwC
  • Harren Jhoti, President and CEO, Astex Pharmaceuticals
  • Ian Schofield, Principal Analyst, Scrip
  • Sukaina Virji, News Editor, Scrip (Chair)

They will share insight on the following key areas:
  • Brexit: what do we actually know?
  • Key concerns around regulation, people, trade and innovation
  • Key elements of the government’s Brexit strategy
  • What opportunities Brexit throws out for UK life sciences

If you have any questions, please don't hesitate to email us at pharma@informa.com
Presenter
Steve Bates
Chief Executive Officer
BIA
View Biography
Presenter
Virginia Acha
Executive Director
ABPI
View Biography
Presenter
Jo Pisani
Partner
PwC
View Biography
Presenter
Lindsey Barras
Director in Global Immigration
PwC
View Biography
Presenter
Harren Jhoti
President and CEO
Astex Pharmaceuticals
View Biography
Presenter
Ian Schofield
Principal Analyst
Scrip
View Biography
Presenter
Sukaina Virji
News Editor
Scrip (Chair)
View Biography

Registration details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

Submit